Literature DB >> 21164270

Optimal glucocorticoid therapy.

Miguel Debono, Richard J Ross.   

Abstract

The rhythmic regulation of human physiology and behaviour is controlled by a central endogenous clock located in the suprachiasmatic nucleus. Most tissues have peripheral clocks that oscillate in time with this central clock. How the central time keeper controls peripheral clocks is not established, however there is evidence to suggest that the cortisol rhythm is one important secondary messenger. Loss of the endogenous cortisol rhythm is associated with sleep disturbance, depression, and metabolic abnormalities. In adrenal insufficiency, current glucocorticoid replacement regimens cannot replace the normal circadian rhythm of cortisol, and patients have an increased mortality and impaired quality of life. We propose that reproducing circadian cortisol levels may improve quality of life in patients with adrenal insufficiency and we have been investigating the impact of circadian hydrocortisone replacement. Using Chronocort, a modified release preparation of hydrocortisone, we have demonstrated that it is possible to simulate the overnight rise in cortisol release and, in preliminary studies in patients with congenital adrenal hyperplasia, control morning androgen levels. Future studies are now required to determine whether Chronocort can improve quality of life in patients with adrenal insufficiency.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164270     DOI: 10.1159/000321241

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  4 in total

Review 1.  Management of congenital adrenal hyperplasia in childhood.

Authors:  Mimi S Kim; Anna Ryabets-Lienhard; Mitchell E Geffner
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

2.  PlenadrEMA: effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments: a study protocol for an open-label switch pilot study.

Authors:  Victor Brun Boesen; Thea Christoffersen; Torquil Watt; Stina Willemoes Borresen; Marianne Klose; Ulla Feldt-Rasmussen
Journal:  BMJ Open       Date:  2018-01-23       Impact factor: 2.692

Review 3.  The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids.

Authors:  Henrik Oster; Etienne Challet; Volker Ott; Emanuela Arvat; E Ronald de Kloet; Derk-Jan Dijk; Stafford Lightman; Alexandros Vgontzas; Eve Van Cauter
Journal:  Endocr Rev       Date:  2017-02-01       Impact factor: 19.871

4.  Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects.

Authors:  Natalie Bordag; Sebastian Klie; Kathrin Jürchott; Janine Vierheller; Hajo Schiewe; Valerie Albrecht; Jörg-Christian Tonn; Christoph Schwartz; Christian Schichor; Joachim Selbig
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.